Ticagrelor 90mg is an oral antiplatelet medication used to reduce the risk of cardiovascular events such as heart attack and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. Unlike other antiplatelet agents, Ticagrelor directly inhibits platelet activation and aggregation by reversibly blocking the P2Y12 receptor on platelets. It works rapidly and provides consistent platelet inhibition, which helps prevent the formation of harmful blood clots. This medication is often prescribed alongside low-dose aspirin to provide dual antiplatelet therapy for optimal cardiovascular protection. Ticagrelor 90mg is well-tolerated but should be used under medical supervision, especially in patients with bleeding disorders or a history of stroke.
